The platform
Platform
Musculoskeletal pathologies are a spectrum of conditions spanning from mild patient discomfort to permanent debility with serious quality of life implications.
The Ceres Difference
Ceres is a tissue repair strategy designed to exert healing effects on muscles, tendons, bones, cartilage, ligaments, and nerves. These perinatal derivatives are sourced from components of the amnion-chorion complex, each possessing a unique composition of collagens, proteins, and factors believed to aid in healing and regeneration.
Hydrated allografts preserve structural proteins in a high molecular weight, native conformation. Preservation of the structure-function is necessary for efficient repair. Minimalistic processing incorporates key proteoglycan components lost in dehydrated allografts.
Leveraging ‘amniogenic intelligence’, this technology aims to improve patient outcomes for challenging musculoskeletal conditions—especially those for which there are currently no highly effective treatments.
Advancing Regenerative Medicine with Access for All
We are committed to advancing healthcare equity by providing safe, effective, and accessible tissue repair solutions to all patients, regardless of insurance/ socioeconomic status. Ceres products are developed by a surgeon/scientist (MD/PhD) practicing in a disproportion-services hospital. By vertically integrating with partnering facilities, Ceres is incorporated into the entire tissue continuum, from recovering amniotic tissue with Labor and Delivery partner sites, to processing and manufacturing of the allografts. This model ensures quality at a drastically reduced cost.